26^th Global Nephrology, Urology and Kidney Failure Congress

Urological Oncology: Current Trends

Urological oncology has seen significant advancements in recent years, improving the diagnosis, treatment, and management of urological cancers such as prostate, bladder, and kidney cancer. One notable trend is the increasing use of minimally invasive surgical techniques, including robotic-assisted surgery, which enhances precision and reduces recovery times. These approaches are associated with less postoperative pain and quicker return to daily activities. Furthermore, the development of targeted therapies and immunotherapy has transformed the treatment landscape, particularly for advanced-stage cancers. Agents that specifically target tumour characteristics offer more effective options with potentially fewer side effects than traditional chemotherapy. Additionally, biomarkers are becoming integral in personalizing treatment plans, allowing for tailored therapies based on individual tumour profiles. Advances in imaging technologies, such as MRI and PET scans, facilitate earlier detection and better monitoring of disease progression. Multidisciplinary care teams are becoming more common, ensuring comprehensive management that addresses not only the cancer but also the physical and emotional well-being of patients. As research continues, urological oncology is poised for further innovations that will enhance patient outcomes and quality of life.